What opportunities get created as fields converge? What challenges surface as markets, policies, and investing dynamics shift? What new scientific discoveries are potential game-changers? Convergence exists to explore those questions (and many others), with a high-level audience interested in what's happening in the rapidly-converging worlds of biotech, pharma, healthcare, medical devices, and the Internet.
The Convergence Forum fosters real debate and discussion among audiences that are every bit as high-level as the speakers. The programs provide an opportunity for participants to make important new contacts, do business, explore important new directions in research, delve deeply into what it takes to maintain competitive advantage in a fast-changing world, and leave feeling recharged.
Company Details
- Employees
- 8
- Founded
- -
- Address
- Charles Street Station, #140386, Boston,massachusetts 02114,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://convergenceforum.com/
- Keywords
- healthcare, life sciences, conference.
- HQ
- Boston, Massachusetts
Convergence Forum Questions
Convergence Forum's website is http://convergenceforum.com/
Convergence Forum's LinkedIn profile is https://www.linkedin.com/company/convergence-forum
Convergence Forum has
8 employees.
View email and phone details for 8
employees at Convergence Forum.
Convergence Forum's industry is
Biotechnology Research
Convergence Forum's top competitors are
Innolead,
Aeglea Biotherapeutics,
The Chatham Conference (Formerly The Nantucket Conference),
Seaport Therapeutics,
Reconstruct Bio,
Acrivon Therapeutics, Inc.,
Termeer Institute,
Medexecwomen,
Vigil Neuroscience,
Gsas Harvard Biotech Club.
Convergence Forum's categories are Biotechnology Research
Convergence Forum's founding year is 2004
